Typical Dosing for Intramuscular Testosterone Enanthate
The standard intramuscular dose of testosterone enanthate is 75-100 mg weekly, or alternatively 150-200 mg every 2 weeks, with weekly dosing preferred for more stable testosterone levels. 1, 2
Recommended Dosing Regimens
The Endocrine Society Clinical Practice Guidelines consistently recommend:
- Weekly dosing: 75-100 mg IM weekly
- Every-two-week dosing: 150-200 mg IM every 2 weeks
- Alternative weekly: 50 mg weekly (lower end of range) 3
Weekly administration is generally preferable because it produces less fluctuation in serum testosterone levels compared to every-two-week dosing, reducing the peaks and valleys that can cause symptom cycling 3. Some patients experience early peak-related symptoms (acne, mood changes, fluid retention) and late-cycle hypogonadal symptoms (fatigue, reduced libido) with less frequent dosing 4.
Target Testosterone Levels
Therapy should aim to achieve mid-normal range testosterone levels (400-700 ng/dL or 14-24 nmol/L) 2. When monitoring:
- Measure testosterone levels midway between injections for every-two-week dosing
- For weekly dosing, measure one week after injection (trough level)
- Adjust dose or frequency if testosterone is >700 ng/dL or <400 ng/dL 2
Dosing Flexibility Based on Clinical Response
More frequent, lower-dose regimens may be warranted when patients experience:
- Symptom cycling between injections
- Early acne, oily skin, or mood disturbance
- Breast tenderness or fluid retention
- Hematocrit elevation >54%
- Low SHBG levels 4
In these cases, consider twice-weekly (e.g., 50 mg twice weekly) or even more frequent administration to smooth testosterone exposure 4.
Important Monitoring Considerations
- Initial monitoring: Check testosterone and hematocrit at 3-6 months 2, 5
- Ongoing monitoring: Annual testosterone and hematocrit checks
- Stop therapy if hematocrit exceeds 54% until it decreases to safe levels 2
- For men ≥40 years with baseline PSA >0.6 ng/mL, monitor PSA and perform digital rectal exam at baseline, 3-6 months, then per screening guidelines 2
Common Pitfalls to Avoid
Defaulting to every-two-week dosing without considering weekly administration - Weekly dosing often provides better symptom stability 3
Escalating total weekly dose when the issue is timing - Redistributing the same weekly dose more frequently may resolve symptoms better than increasing total dose 4
Measuring testosterone at inconsistent times - Always document timing of last injection and blood draw; results are uninterpretable without this context 2, 4
Ignoring cardiovascular safety signals - Some evidence suggests injectable testosterone may carry higher cardiovascular risk than transdermal formulations, possibly due to supraphysiologic peaks and subtherapeutic troughs 3
FDA-Approved Formulation
Testosterone enanthate is supplied as 200 mg/mL for intramuscular use 6. The medication is absorbed slowly from the lipid phase after IM injection, with approximately 98% bound to sex hormone-binding globulin in plasma 6.